Associating clinical outcomes and number of antiseizure medications in refractory status epilepticus
The results of this study suggest that patients requiring ≥ 4 ASMs for treatment of SE have worse neurological outcomes. These results may inform treatment preferences for refractory SE and provide data for risk-benefit discussions.
Authors
- Brittany Cunningham (ORCID: https://orcid.org/0000-0002-9034-8996)
- Melissa Fowler (ORCID: https://orcid.org/0000-0003-0602-820X)
- Enyinna L. Nwachuku (ORCID: https://orcid.org/0000-0002-4945-3647)
- Jacob Smearman
Institutions
- Cleveland Clinic (US)
- Cleveland Clinic Akron General (US)
Publication Details
- Journal
- Epilepsy Research
- Published
- 2025-04-03
- DOI
- https://doi.org/10.1016/j.eplepsyres.2025.107547
- Primary Topic
- Epilepsy research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00